Clinical trial footprint Position CRI as a geographically strategic partner given its location near major Southern California markets (San Bernardino, Orange, Riverside, Los Angeles). Emphasize access to a diverse patient pool and proximity to airports for multi-site or remote-enabled trial logistics.

Therapeutic breadth Highlight the extensive multi-specialty capabilities and experience conducting Phase II–IV trials to attract sponsors seeking a single-site, comprehensive clinical research facility for a range of therapeutic areas.

Financial scale Leverage the current revenue range to propose phased engagement options, including feasibility studies, site start-up support, and fast-track trial initiation services tailored to mid-market sponsors seeking mid- to large-scale trials.

Ownership transition Due to acquisition by Latticework Capital Management, present continuity assurances, governance alignment, and potential integration offerings with sponsors seeking stable, backed partnerships and access to capital resources.

Tech-enabled operations Market CRI’s technology stack as a modern, secure infrastructure for trial data handling, patient recruitment, and regulatory submission readiness, appealing to sponsors prioritizing compliant, streamlined, technology-driven trial management.